Lewin, J., Malone, E., Al-Ezzi, E., Fasih, S., Pedersen, P., Accardi, S., Gupta, A., & Abdul Razak, A. (2021). A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS). Eur J Cancer, 144, 360-367. https://doi.org/10.1016/j.ejca.2020.10.032

Lewin, J., Malone, E., Al-Ezzi, E., Fasih, S., Pedersen, P., Accardi, S., Gupta, A., & Abdul Razak, A. (2021). A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS). Eur J 

Cancer, 144, 360-367. https://doi.org/10.1016/j.ejca.2020.10.032